These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 37888964)
1. Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer. Lohajová Behulová R; Bugalová A; Bugala J; Struhárňanská E; Šafranek M; Juráš I Physiol Res; 2023 Oct; 72(S3):S193-S207. PubMed ID: 37888964 [TBL] [Abstract][Full Text] [Related]
2. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer. Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209 [TBL] [Abstract][Full Text] [Related]
3. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer. Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216 [TBL] [Abstract][Full Text] [Related]
4. Identification of reference genes for circulating microRNA analysis in colorectal cancer. Niu Y; Wu Y; Huang J; Li Q; Kang K; Qu J; Li F; Gou D Sci Rep; 2016 Oct; 6():35611. PubMed ID: 27759076 [TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243 [TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer. Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review). Liang X; Wu Q; Wang Y; Li S Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382661 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of non-small cell lung carcinoma by circulating microRNA. Singh A; Kant R; Saluja TS; Tripathi T; Srivastava K; Naithani M; Gupta A; Mirza AA; Prakash V; Singh SK J Cancer Res Ther; 2020; 16(1):127-131. PubMed ID: 32362622 [TBL] [Abstract][Full Text] [Related]
11. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Clancy C; Joyce MR; Kerin MJ Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322 [TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer. Müller S; Janke F; Dietz S; Sültmann H Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236 [TBL] [Abstract][Full Text] [Related]
13. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer. Shi Y; Zhuang Y; Zhang J; Chen M; Wu S Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035 [TBL] [Abstract][Full Text] [Related]
14. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer. Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M Oncology; 2018; 94(5):311-323. PubMed ID: 29533963 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer. Jiang YF; Wei SN; Geng N; Qin WW; He X; Wang XH; Qi YP; Song S; Wang P Sci Rep; 2022 Oct; 12(1):17201. PubMed ID: 36229645 [TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients. Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320 [TBL] [Abstract][Full Text] [Related]
18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis. Tao S; Ju X; Zhou H; Zeng Q Int J Biol Markers; 2020 Dec; 35(4):51-60. PubMed ID: 33103527 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related] [Next] [New Search]